U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07486102) titled 'A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems' on March 17.
Brief Summary: This study is open to healthy people and people with liver problems. Adults between 18 and 80 years can participate. The purpose of this study is to compare how a medicine called BI 3000202 is handled by the body in people with and without liver problems.
All participants take 1 tablet of BI 3000202. Participants with liver problems may also continue their regular treatment for their liver condition.
Participants are in the study for about 1 month. During this time, participants visit the study site about...